Skip to main content

Table 2 Other demographical data and clinical presentations

From: Improvement of antibiotic therapy and ICU survival in severe non-pneumococcal community-acquired pneumonia: a matched case–control study

Variable

CAPUCI I group

CAPUCI II group

p value

(n = 72)

(n = 72)

Agea

63.0 (47.5–75.0)

62.0 (53.0–72.0)

0.85

Age under 50 years

20 (27.8)

14 (19.4)

0.33

Age 50–64 years

20 (27.8)

24 (33.3)

0.59

Age 65–74 years

13 (18.1)

20 (27.8)

0.23

Age over 75 years

19 (26.4)

14 (19.4)

0.43

Male gender

49 (68.1)

54 (75.0)

0.46

Active smoker

25 (34.7)

27 (37.5)

0.86

Alcohol use

24 (33.3)

14 (19.4)

0.09

Overweight

14 (19.4)

21 (29.2)

0.24

Diabetes mellitus

18 (25.0)

15 (20.8)

0.69

Cardiomyopathy

24 (33.3)

17 (23.6)

0.27

Cerebral vascular disease

4 (5.6)

7 (9.7)

0.53

Malignancy

6 (8.3)

4 (5.6)

0.75

Estimated probability of deatha

32.0 (19.5–50.0)

34.0 (16.0–62.8)

0.59

ICU length of staya

10.5 (6.0–20.8)

12.0 (7.0–33.0)

0.16

Days of mechanical ventilationa

8.0 (4.0–15.3)

10.5 (6.0–23.3)

0.18

Bacteremia

16 (22.2)

22 (30.6)

0.35

Acute kidney injury

31 (43.1)

29 (40.3)

0.87

Rapid radiographic spread

40 (55.6)

37 (51.4)

0.74

ICU mortality

25 (34.7)

12 (16.7)

0.02

  1. Data are presented as n (%), unless otherwise indicated: a median (interquartile range 25–75). ICU intensive care unit. Significant p values are indicated in bold